Equities.com Article – “ARCA biopharma (ABIO): Genetically Targeting Cardiovascular Disease” Posted on June 12, 2017 by ARCA IT - Uncategorized https://www.equities.com/news/arca-biopharma-abio-genetically-targeting-cardiovascular-disease
ARCA biopharma Announces First Quarter 2017 Financial Results and Provides Business Update Posted on May 15, 2017 by ARCA IT - Press Release, Uncategorized 2017 Q1 Financial Results and Business Update - FINAL
ARCA biopharma Announces 200th Patient Randomized into the GENETIC-AF Seamless Design Phase 2B/3 Clinical Trial Posted on April 26, 2017 by ARCA IT - Press Release, Uncategorized GENETIC-AF - 200 Patients - FINAL
ARCA biopharma 2017 Annual Stockholders Meeting, June 1st, 2017 9am MDT Posted on April 21, 2017 by ARCA IT - Press Release arca_2017_proxy
ARCA biopharma to Present at the Planet Microcap Showcase 2017 Investor Conference Posted on April 18, 2017 by ARCA IT - Press Release, Uncategorized Investor Showcase 2017 Conf annc – FINAL
ARCA biopharma Announces Fiscal Year 2016 Financial Results and Provides Business Update Posted on March 21, 2017 by ARCA IT - Press Release, Uncategorized 2016 Financial Results and Business Update - FINAL
ARCA biopharma Announces 175th Patient Randomized into the GENETIC-AF Phase 2B/3Clinical Trail Posted on March 6, 2017 by ARCA IT - Press Release, Uncategorized GENETIC-AF - 175 Patients - FINAL
Anders Hove, MD Joins ARCA Board of Directors Posted on February 21, 2017 by ARCA IT - Press Release, Uncategorized Dr Anders Hove Joins BOD - FINAL
ARCA BIOPHARMA ANNOUNCES 150TH PATIENT RANDOMIZED INTO THE GENETIC-AF PHASE 2B/3 CLINICAL TRIAL Posted on January 18, 2017 by ARCA IT - Press Release, Uncategorized GENETIC-AF - 150 Patients - FINAL
ARCA BIOPHARMA TO PRESENT AT BIOTECH SHOWCASE 2017 Posted on January 4, 2017 by ARCA IT - Press Release, Uncategorized biotech-showcase-2017-conf-annc-final